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Background: The rapidly increasing number of engineered nanoparticles (NPs), and products containing NPs, raises
concerns for human exposure and safety. With this increasing, and ever changing, catalogue of NPs it is becoming
more difficult to adequately assess the toxic potential of new materials in a timely fashion. It is therefore important
to develop methods which can provide high-throughput screening of biological responses. The use of omics
technologies, including metabolomics, can play a vital role in this process by providing relatively fast, comprehensive,
and cost-effective assessment of cellular responses. These techniques thus provide the opportunity to identify specific
toxicity pathways and to generate hypotheses on how to reduce or abolish toxicity.
Results: We have used untargeted metabolome analysis to determine differentially expressed metabolites in human
lung epithelial cells (A549) exposed to copper oxide nanoparticles (CuO NPs). Toxicity hypotheses were then generated
based on the affected pathways, and critically tested using more conventional biochemical and cellular assays. CuO
NPs induced regulation of metabolites involved in oxidative stress, hypertonic stress, and apoptosis. The involvement
of oxidative stress was clarified more easily than apoptosis, which involved control experiments to confirm specific
metabolites that could be used as standard markers for apoptosis; based on this we tentatively propose
methylnicotinamide as a generic metabolic marker for apoptosis.
Conclusions: Our findings are well aligned with the current literature on CuO NP toxicity. We thus believe
that untargeted metabolomics profiling is a suitable tool for NP toxicity screening and hypothesis generation.
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With the growing catalogue of engineered nanoparticles
(NPs) found in consumer products and in approved or
under-development therapeutics [1, 2], there are general
safety concerns regarding the implications of perceived
exposure that may accompany the widening spectrum of
NPs in use. Moreover, with the high projected industrial
growth of nanotechnology, particularly of metal oxides,
there is a real concern for workplace safety, with the
relevant workforce potentially at risk from occupational
inhalation exposure [3]. During the expansion of these
products there has been a conscientious effort to
address safety concerns and to determine the risks
involved in human exposure. However, the current
understanding is still insufficient to provide suitable
recommendations for regulatory decisions [4]. This
common international goal may be aided by developing
methods for high-throughput screening of NPs and
methods which allow the collection of multiple bio-
logical endpoints in one assessment; in this way, we
may be able to address the exponential growth of NPs
within the public domain.
The use of omics methodologies in the assessment of
the physiological effects may provide a suitable platform
and, therefore, has received much interest in evaluating
NP-induced toxicity. Comprehensive omics approaches
are ideally suited to investigate the multitude of potential
effects that NP exposure exerts on cells, tissues or even
whole organisms, since they provide a holistic view on
what is going on at the protein or at the metabolite level.
Proteomics has received much interest and has been
used to show the fate of NPs exposed to physiological
surroundings such as plasma [5] and the effects of NPs
at a cellular [6] or even at the organism level [7]. Some-
what more directly, metabolomics detects phenotype
changes and could therefore deliver valuable information
on the toxic effects of NP treatment [8]. Two main tech-
nical approaches are suitable to comprehensively detect
differences on relative metabolite abundances dependent
on NP treatment, in an untargeted fashion: nuclear
magnetic resonance-based techniques [9–11] and mass
spectrometry (MS)-based approaches. In particular MS-
based approaches have seen tremendous technological
developments and combine a high sensitivity with excel-
lent resolution power. The increasing amount of data
generated by the latest generation of instruments in turn
requires more and more sophisticated bioinformatics
tools for data evaluation [12–14]. The growing compre-
hensiveness of these profiling experiments has thus
raised hopes that it can help uncover molecular mecha-
nisms associated with NP exposures. However, the scarcity
of studies utilising metabolomics in nanotoxicology has
been highlighted in a recent review by Lv et al. [15], albeit
these applications can be quite diverse, with measurementsmade of metabolites differentially expressed and excreted
in urine, found in serum, identified in organs such as the
liver, or assessed intracellularly or extracellularly in in vitro
studies. The current literature mainly addresses exposure
to TiO2 and SiO2 NPs, but there are also examples of stud-
ies on silver-, zinc-, copper-, carbon nanotube-materials
(CNTs), amongst others [15]. Assessment of a cells’ whole
metabolome provides an assessment of cellular responses
at a molecular level [15], and changes within this upon NP
exposure can provide a magnitude of information if
assessed correctly; it would be possible to assign specific
markers for known toxicity paradigms, and, furthermore,
give insights into novel intracellular events. This can allow
a platform for both high-throughput screening, but also
for toxicity hypothesis generation.
For the purpose of this study copper oxide nanoparti-
cles (CuO NPs) were chosen; as extensive studies on the
toxicity mechanisms already exist, CuO NPs provide an
excellent model particle for use in this study. Further-
more, with tangible potential for exposure the concern
for human health is understandable. Historically, copper
mines and smelting facilities have presented a high risk
of occupational exposure, reported to induce various re-
spiratory complications [16]. Presently CuO NPs are
produced on a large-scale basis [17], and although in-
dustrial control of these materials has improved, facil-
ities may vary in their exposure levels dependent upon
ventilation systems [18]. The reduced size and increased
surface area of CuO NPs compared to bulk material
results in the NP form having improved thermoconduc-
tivity and fluid viscosity, as well as enhanced Cu ion
release; this has led to an assortment of applications,
including their use as chemo-sensors, in chemical cataly-
sis, as surfactants and antimicrobials. However, these
prolific applications may also allow for greater opportun-
ities for human exposure [19]. Copper, mostly in its
ionic Cu2+ form, is involved in many biological func-
tions, it is an essential trace element and therefore sub-
ject to strict homeostatic control [20]. It is, for instance,
incorporated into redox active proteins, mainly in the
prosthetic groups of enzymes and thus turned over,
recycled, and eventually excreted [21–23].
With perceived increases in exposure through manu-
facturing and recycling of products and increased use of
Cu NPs, the toxicity to humans and any safety concerns
need to be assessed. The toxicity of CuO NPs has there-
fore been studied intensively, also because its toxicity is
particularly pronounced compared to other NPs [24]. It
has been shown in vitro that CuO NPs induce cytotox-
icity in numerous cell types [25], including A549 cells
[26], often related to apoptosis [26, 27], and occurring
concomitantly with genotoxicity [26, 28] and oxidative
stress [29, 30]. It has been proposed that the mode of ac-
tion for CuNP toxicity lies with the delivery and
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Trojan horse mechanism [31]; identified when bio-
logical responses to CuO NPs were found to be greater
than those to micrometre sized copper particles or to
soluble copper chloride (CuCl2) [26, 30]. Cytotoxicity
of CuO NPs was shown to be reduced when particles
were stabilised, and released fewer ions [31]. Both
these key pathways, oxidative stress and apoptosis,
have also been demonstrated in response to CuO NPs
in vivo [32].
Using the A549 (adenocarcinoma human alveolar
basal epithelial) cell line, a well-established and fre-
quently used model for the assessment of NP-induced
lung toxicity, we have used untargeted metabolomics as
a platform for toxicity profiling of CuO NPs and as a
tool for hypothesis generation, focussing on two well-
reported pathways of CuO NP-induced toxicity, oxidative
stress and apoptosis. These hypotheses were subsequently
critically tested by targeted follow-up studies assessing the
proposed toxicity pathways by dedicated cell assays. In this
proof of principle study, it was expected that the CuO
NPs that were tested would induce both oxidative stress
and apoptosis, and, therefore, that specific markers within
the metabolome would be identified as being linked to
these toxicity pathways.
We were able to link the generated metabolome pro-
files generated in A549 cells to mechanisms of toxicity.
Furthermore, we have identified specific indicator me-
tabolites for several pathways, including oxidative stress
and apoptosis. We were also able to deduce a more
detailed mechanism by which CuO NPs trigger these
pathways. These findings suggest that untargeted meta-
bolomics can be applied in early screening of NP toxicity
and is advantageous for generating toxicity hypotheses




CuO NPs were obtained from Intrinsiq Materials Ltd
(Farnborough, UK) and were supplied by the Nanovalid
consortium (http://www.nanovalid.eu/). Acetonitrile (ACN)
for LC-MS was purchased from VWR (Radnor, PA, USA).
High-purity water (H2O) was produced using a Milli-Q
Integral three purification system from Merck Millipore
(Darmstadt, Germany). Standard substances used for
identification were obtained from Merck (amino acids).
Staurosporine (STS) was purchased from Proteinkinase.de
(Kassel, Germany), camptothecin (CPT) from Abcam
(Cambridge, UK), and rhTNF-α from Immunotools
(Friesoythe, Germany). SYBR Green Supermix was
purchased from Bio-Rad (Munich, Germany), RevertAid
HMinus M-MulV reverse transcriptase from Fermentas
(St. Leon-Roth, Germany), TRIzol reagent from Invitrogen,IL-8 ELISA kits from PeproTech, while Celltiter-Blue®
(CTB) Cell Viability Assay was purchased from Promega
(Madison, WI, USA), foetal calf serum (FCS) from PAA
(Pasching, Austria). All other substances used were
obtained from Sigma-Aldrich (St. Louis, MO, USA).
Cell culture and treatment
The A549, human lung alveolar adenocarcinoma cell
line, was purchased from ATCC and maintained in
150 cm2 flasks using RPMI 1640 medium supplemented
with 10 % foetal calf serum (FCS), 1 % L-glutamine, 100
U/ml Penicillin, and 100 μg/ml Streptomycin, at 37 °C
and 5 % CO2. To subculture, or seed cells for experi-
ments, cells were trypsinized, centrifuged at 320 x g for
5 min, resuspended in cell culture medium (CCM), and
viability determined by trypan blue exclusion. Cells were
seeded 1 day prior to experiments at 2 x 105 cells per
cm2 of culture dish, in either 96-, 24-, or 6-well plates,
depending upon experimental protocol. A549 cells were
exposed to the following agents: CuO NPs, copper
chloride (CuCl2), CPT, STS (positive control in apoptosis
assays), TNF-α (positive control in pro-inflammatory
mediator release), and Triton X-100 (positive control in
cytotoxicity assays); exposure time and treatment con-
centration were dependent on assay.
Characterization of copper oxide nanoparticles
Characterisation was performed at a CuO NP concen-
tration identical to that used in the metabolomics
study (10 μg/ml). The hydrodynamic diameter and an
estimation of surface charge of CuO NPs were deter-
mined by dynamic light scattering (DLS) and zeta po-
tential measurements, respectively, using a Malvern
ZetaSizer Nano ZSP (Malvern Instruments, Malvern,
UK). CuO NPs were suspended in dH2O or CCM at
10 μg/ml and sonicated prior to measurement. As
substantial agglomeration was observed in DLS mea-
surements, primary particle size was also determined
by transmission electron light microscopy (TEM).
CuO NPs, suspended in dH2O, were added to TEM
grids and dried prior to imaging using a LEO 912 AB
Omega transmission electron microscope (Zeiss,
Oberkochen), operated at 120 kV with a LaB6 cath-
ode. Size distributions were calculated using ImageJ
software (National Institutes of Health, Bethesda, MD,
USA), taking at least 1000 measurements. Dissolution
of CuO NPs was assessed, in triplicate, in full CCM.
NPs were incubated at 10 μg/ml for 0 h, 1 h, 3 h,
6 h, 12 h, 24 h, 48 h, at 37 °C. After incubation, the
samples were centrifuged at 25,000 x g for 30 min
and the supernatant was used for Cu2+ determination
by inductively coupled plasma atomic emission spectros-
copy (ICP-AES), using an Activa instrument (Horiba Jobin
Yvan, Unterhaching, Germany).
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tate dehydrogenase (LDH) quantification in the cell
supernatant and the CTB Cell Viability Assay, respect-
ively. Three biological replicates were performed. A549
cells were exposed to CuO NPs at 0–40 μg/ml, or to
CuCl2 at corresponding copper concentrations of 63–
500 μM for 4, 24 and 48 h. The concentrations used for
CuCl2 exposure relate to the absolute maximum poten-
tial release of Cu2+ from the CuO NPs; based on the
dissolution data, the actual release into the cell culture
medium would have been significantly lower. CTB re-
agent was added to cells in CCM at a ratio of 1:5 and
incubated at 37 °C for 60 min; following this, fluores-
cence intensity was measured at ex/em wavelengths of
560 nm/590 nm on a plate reader (Infinity 200 Pro,
Tecan, Groedig, Austria). LDH present in the super-
natant was determined as a measure of lost membrane
integrity, using a method based on a Sigma diagnostic
kit, as previously described [33, 34]. Medium only
treated cells were used as negative control exposures. In
both assays Triton X-100 (0.1 %) was used as a positive
control. The supernatants from these exposures were
stored at −80 °C for evaluation of secreted interleukin
(IL)-8. These data were used to determine appropriate
particle exposure concentrations and time points for
subsequent assays.
Pro-inflammatory cytokine secretion was assessed
through determination of IL-8 by ELISA, following an
adaption of the manufacturer’s instructions. Briefly, the
capture antibody was added to wells of a 96 well plate
and left at 4 °C overnight, followed by blocking buffer
(1 % BSA in PBS) for 1 h, and subsequently the addition
of standards, at 0–2000 pg/ml, and samples for 2 h. De-
tection antibody, in assay diluent (0.05 % Tween-20 and
0.1 % BSA in PBS), was then added for 2 h, followed by
an avidin-HRP conjugate for 30 min. Each of the preced-
ing steps were separated by wash steps. A TMB substrate
was then added and the reaction was stopped using 2 M
H2SO4. Colour development was measured on a plate
reader (Infinity 200 Pro, Tecan, Groedig, Austria) at
450 nm with a reference wavelength of 650 nm, and IL-
8 concentrations determined using standard curves.
Medium only treated cells were used as negative control
exposures. TNF-α (20 pg/ml) was used as a positive con-
trol for IL-8 secretion by A549 cells. Three biological
replicates were performed.
Gene expression of HO-1 and GPX1 induced by CuO NPs
A549 cells were exposed to CuO NPs at 0–40 μg/ml, for
time periods relating to the metabolomics study of 1, 3,
6, 12 and 24 h. RNA isolation was performed using TRI-
zol reagent and cDNA generation with RevertAid H
Minus M-MulV reverse transcriptase; each following
the manufacturer’s instructions. Quantitative real-timeRTPCR (qRT-PCR) was performed using a Rotorgene
3000 (Corbett Research, Mortlake, Australia), with iQ
SYBR Green Supermix and the following primers:
human GPX1 (Qiagen #PPH00154E); human HO-1
sense, 5’-GCCAAGACTGCGTTCCTGCTCAA-3’, and
antisense, 5’-TCGCCACCAGAAAGCTGAGTGTA-3’;
and human RPLP0 sense, 5’-GGCACCATTGAAATCC
TGAGTGATGTG-3’, and antisense, 5’-TTGCGGAC
ACCCTCCAGGAAG-3’. The large ribosomal protein
P0 (RPLP0) was used as a reference gene. Primer specifi-
city was confirmed through assessment of the product
melting curves. Quantification of relative mRNA ex-
pression levels were calculated in relation to the RPLP0
housekeeping gene using the delta delta method of
Pfaffl [35], and normalized to medium only treated
cells (negative control). Three biological replicates were
performed.
Glutathione redox state was determined using the
GSH/GSSG-Glo™ Assay (Promega), following manufac-
turers’ instructions. Briefly, after exposure of A549 cells
to 0–40 μg/ml CuO NPs for time periods relating to the
metabolomics study of 1, 3, 6, 12 and 24 h, cells were
lysed in a passive lysis buffer which contains GSH probe
Luciferin-NT, converts all glutathione into reduced
GSH, and is therefore used to measure total glutathione;
for determination of GSSG, duplicate wells were pre-
pared in which the lysis buffer also contained N-
ethylmaleimide (NEM), which binds GSH preventing its
detection and therefore only assesses the oxidised GSSG.
After lysis, a luciferin generation reagent, containing
Glutathione Reaction Buffer, dithiothreitol (DTT) and
glutathione S-transferase, was added, followed by the
addition of luciferin detection reagent. Luminescence
was then measured in white 96-well plates on a plate
reader (Infinity 200 Pro, Tecan, Groedig, Austria). Lumi-
nescence values were converted to μM GSH concentra-
tions using GSH standard curves (in the case of GSSG
this incorporated a consideration that one mole of oxi-
dized GSSG is reduced to two moles of GSH for detec-
tion within the assay). Medium only treated cells were
used as negative control exposures. Once values for
GSH and GSSG had been determined, data were finally
expressed as a ratio of GSH/GSSG. Four biological repli-
cates were performed.
Caspase activity of A549 cells was determined using
the Apo-ONE® Homogeneous Caspase-3/7 Assay (Pro-
mega), following the manufacturer’s instructions. Briefly,
A549 cells were exposed to CuO NPs (0–20 μg/ml), STS
(0–2 μM), or CPT (0–32 μg/ml), for time periods relat-
ing to the metabolomics study of 3, 6, 12 and 24 h. After
exposure period Caspase-3/7 Reagent was added to
each well at a 1:1 volume ratio, and incubated for 2 h
prior to measurement on a plate reader (Infinity 200
Pro, Tecan, Groedig, Austria), with fluorescence intensity
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were used as negative control exposures, and data was
expressed as a percent of medium only treated cells. Three
biological replicates were performed.
Untargeted metabolomics profiling of CuO NPs,
staurosporine and camptothecin
A549 cells were exposed to 10 μg/ml CuO NPs for 0, 1,
3, 6, 12, and 24 h, 1 μM STS for 0, 3, 6, 12, and 24 h,
and 16 μg/ml CPT for 0, 6, 9, 12, and 24 h. Medium only
treated cells were used as negative control exposures.
The experimental and computational pipeline used for
metabolomics profiling is described in [14]; the main steps
and the modifications from the original protocol are as
follows. Three biological replicates were performed.
For metabolite extraction cell culture medium was re-
moved, the cells were washed twice with ice cold PBS
(Sigma-Aldrich), followed by an additional very rapid
washing step with ammonium bicarbonate (185 mmol/l,
289 mOsm, pH 7.8; Sigma-Aldrich). To quench metab-
olism, 750 μL ice cold methanol containing ethylparaben
(10 μmol/l) as an internal standard, was added. A sonic-
ation and centrifugation step followed, which resulted in
a supernatant containing the intracellular metabolites.
These samples were diluted 1:5 with MilliQ water (con-
taining 10 μmol/l nitrotyrosine) and 1:2 with acetonitrile
(containing 10 μmol/l nitrotyrosine) for reversed-phase
(RP-)HPLC-MS and for hydrophilic interaction liquid
chromatography (HILIC)-MS analysis, respectively.
High-performance liquid chromatography-mass
spectrometry (HPLC-MS)
In order to increase the yield of identifiable hydrophilic
metabolites HILIC separation was carried out in addition
to the RP separation which was described in detail in
Ranninger et al. [14]. The HILIC-MS measurements
were performed with a 150 mm x 2 mm Nucleodur col-
umn with 1.8 μm particles (Macherey-Nagel, Düren,
Germany). The mobile phase A contained 90 % aceto-
nitrile and 10 % buffer (100 mM ammonium formate
pH 3.2 adjusted with formic acid) and mobile phase B
consisted of 50 % acetonitrile 40 % MilliQ water and
10 % buffer. Using a flow rate of 300 μl/min, chromatog-
raphy was performed by starting at 100 % A, holding for
3 min followed by a decrease of A to 0 % in 17 min and
holding 0 % for 2 min, finally a re-equilibration step
for 8 min at 100 % A was carried out. The column
temperature was maintained at 30 °C and 2.7 μl of
sample was injected.
The detection was carried out using a quadrupole-
Orbitrap mass spectrometer (Model Q Exactive Plus
Thermo Fisher Scientific, Bremen, Germany) in the mass
range 70–950m/z at a resolution of 70,000. The ESI
heater temperature was set to 350 °C for RP separationand to 250–300 °C for HILIC; an AGC-target of 1 × 106
and a minimum injection time of 50 ms were chosen.
The settings of the tuning parameters for each separ-
ation and ionization mode are summarized in Additional
file 1: Table S1. The data was recorded in profile mode.
The tandem spectra were acquired in data-dependent
mode, by using a top 5 experiment. Therefore the reso-
lution was set to 17,500, the AGC-target to 5 × 104 and
a maximum injection time of 64 ms was selected. For
fragmentation the normalized collision energy (NCE)
was ramped in three steps (20, 40, 60). Furthermore an
isolation window of 0.8m/z, an underfill ratio of 1.5 %,
an intensity threshold of 1.2 × 104, and an apex trigger
of 2 to 5 s were selected. Additionally, m/z values with a
charge higher than 3 as well as isotopes were excluded
for fragmentation. The fragmentation data was recorded
in centroid mode.
Data evaluation for cytotoxicity, cell viability, pro-
inflammatory responses, glutathione redox state, gene
expression, and apoptosis assays
Statistical analysis of data was performed using PASW
statistics 18 (SPSS, IBM), and treatments were consid-
ered statistically significant when p < 0.05. Differences
between exposures of medium only and different
concentrations of CuO NPs, CuCl2, STS or CPT were
determined by ANOVA, with post hoc Tukey compari-
sons for pairwise analysis. Specific comparisons of CuO
NPs versus CuCl2 were made using an independent
samples t-test.
Data evaluation for untargeted metabolomics
Both chromatograms and mass spectra were recorded
with Xcalibur 3.0.63 (Thermo Fisher Scientific). The
generated HPLC-MS raw data was converted to mzML
data with ProteoWizard 3.0.4243 (http://proteowizard.
sourceforge.net/, [36]). All mzML files belonging to one
separation and ionization mode were further processed
together using OpenMS 1.11 (www.OpenMS.de, [37]),
KNIME 2.11.2 (https://www.knime.org/, [38]), R 2.15.1
(www.r-project.org, [39]), and SIMCA 13.0.3 (Umetrics,
Umea, Sweden).
Metabolomics data was normalized to total cell num-
ber as follows. For each time point and condition the
mean cell number was calculated. As trypsinization is
known to introduce artefacts in HPLC-MS assays, an
additional set of cells, with identical treatments were
prepared. Cell counting was performed using trypan blue
exclusion on a haemocytometer. The resulting cell num-
bers are shown in Additional file 1: Tables S2 and S3.
An important aspect in metabolomics data interpret-
ation in regards to in vitro toxicity testing relates to how
to prepare data for pattern recognition and biological in-
terpretation. For this it is necessary to monitor cell
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are used, or, if necessary, to account for differences in
cell numbers, as the exposure of cells to a toxic sub-
stance can lead to cell growth arrest or cell death, while
control (untreated) cells would be viable and therefore
growing and dividing. This can result in different viable
cell numbers between control and treated groups, dis-
torting the relative comparison between them. This may
influence data interpretation through a drop in a specific
metabolite being perceived as something other than a
simple drop in cell number, or, conversely, a rise in a
specific metabolite not being detected as the overall viable
cell number was lower. Therefore, the normalization of
detected metabolites is essential in order to correctly de-
termine whether the observed differences in the metabol-
ite profiles is due to the treatment and not to varying cell
numbers. Various normalization methods can be applied
in metabolomics, such as the wet weight of cells, the cell
number, protein or DNA concentration, or even using a
comparison to “housekeeping” metabolites [40].
For this CuO NP study all these parameters for
normalization were evaluated (data not shown) using
cells seeded at different densities to assess how the
above mentioned parameters are changed dependent of
cell number; which were then further compared to un-
treated and CuO NP-treated cells after a 24 h exposure
period. Although it is a frequently used method for
normalization, TIC normalization did not correspond
well to cell number. Instead, we found the use of a house-
keeping metabolite, namely N-acetylaspartylglutamic acid,
particularly effective. However, this is a laborious proced-
ure, as a housekeeping metabolite has to be evaluated for
each cell system as well as for the treatment and the study
design separately. We consider normalization to total
DNA an elegant solution, although, again, this is a long
and laborious method. Furthermore, in our hands, the
patterns of detection were not consistent within the
control experiments performed, which may be due to an
inadequate DNA extraction and measurement protocol.
Ultimately, the normalization to total cell number was
chosen. The metabolic expression patterns were found to
be consistent with our control experiments, and as the
experimental time and complexity of this method is rela-
tively low, it was considered the most appropriate option
to provide a time- and cost-effective method for unbiased
determination of the cells’ metabolome.
The data evaluation was carried out according to the
procedure described in [14] with minor changes men-
tioned below. The OpenMS tool FeatureFinderMetabo has
the option to set a noise threshold, which varies a lot de-
pending on the separation method, the MS instrument, the
ionization mode as well as on the sample. The following
settings for the noise threshold were used for the various
metabolomics datasets CuO_RP_pos_intracellular 100,000;CuO_RP_neg_intracellular 20,000; CuO_HILIC_pos_intra-
cellular 150,000; CuO_HILIC_neg_intracellular 50,000;
Apoptosis_RP_pos: 30,000; Apoptosis_HILIC_neg: 30,000.
From the resulting OpenMS feature list we removed
chemical noise and background signals: for each de-
tected feature the median intensity in the blank was not
allowed to exceed 20 % of the sample intensity for 30
out of 36 samples. Subsequently the relative standard de-
viation (RSD) of the two internal standards ethylparaben
and nitrotyrosine was evaluated, which had to be less
than 20 % in all samples in order to be used for differen-
tial analysis (Additional file 1: Table S4). These features
were normalized using the cell number, which was ac-
quired in an additional experiment (see Additional file 1:
Tables S2 and S3). The peak area of each feature was
divided by the according mean cell number in order to ac-
count for cell growth and death occurring during the 24 h
of treatment. Furthermore, only m/z values were used for
statistical analysis, which were stable in the pool sample as
demonstrated by less than 25 % RSD in peak areas.
The feature numbers gained in the different steps of
raw data processing are collected in Additional file 1:
Table S5. The features detected by HILIC- and RP-
HPLC-HRMS after QC filtering were compared using
the exact mass information that had to match within
±5 ppm. The result is illustrated in a Venn diagram
(Additional file 1: Figure S1) and shows just a small
overlap between the two separation modes. Using both
separation methods a greater number of features could
be detected allowing a more comprehensive analysis of
the metabolic signature.
Data was statistically evaluated using principal compo-
nent analysis (PCA), and a univariate statistical approach,
namely linear models for microarray data (limma) followed
by Benjamini-Hochberg correction for multiple testing.
The differentially expressed features were identified,
whereas the reliability of the assigned identification is indi-
cated as proposed by the guidelines of Sumner et al. [41].
Significantly regulated features were identified by
searching the exact feature masses with a maximum de-
viation of 5 ppm in the human metabolite database
(HMDB). Subsequently, confirmation of these putative
hits was done by MS2 fragment spectra comparison with
databases such as Metlin [42] (level 2). Finally, if avail-
able, the measurement of reference compounds enabled
the comparison of chromatographic retention times,
exact mass (level 1a) and the fragmentation patterns
(level 1) of the reference compound and the metabolite
to be identified.
Results
Characterization of CuO nanoparticles
CuO NP characteristics are given in Table 1 and Fig. 1.
The primary particle size was determined to be 28.2 nm
Table 1 Copper oxide nanoparticle properties including source
of material, surface charge in water and in cell culture medium
(CCM), and size determined by DLS in water and in CCM, and
by transmission electron microscope micrographs
Properties CuO NPs
Source Intrinsiq
Zeta potential in water (mV) +35.9 ± 1.3
Zeta potential in CCM (mV) −10.5 ± 0.1
Size (determined by DLS) in water (d.nm) (Z-av.) 172.0 ± 7.6 (PDI 0.188)
Size (determined by DLS) in CCM (d.nm) (Z-av.) 214.2 ± 14.8 (PDI 0.507)
TEM size (nm) 28.2 ± 13.7
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(±7.6) or 214.2 nm (±14.8) were shown to form when
CuO NPs were suspended in water or CCM, respect-
ively. In CCM the particle suspension was shown to con-
tain three distinct peaks of agglomerate sizes (Fig. 1d),
also highlighted by a high polydispersity index (PDI) of
0.507; in water the PDI was far lower, at 0.188, and only
one size distribution peak was observed (Fig. 1c). When
in water, the CuO NPs presented a positive surface
charge of +35.9 mV (±1.3), which became negative when
suspended in CCM (−10.5 mV ±0.1); which is likely due
to the coating of NPs with protein components of the
CCM, as has previously been shown [34]. As CuO NPsFig. 1 Characterization of CuO NPs. Including (a) dissolution of 10 μg/ml C
represented as 100 % dissolution), black entries represent Cu ions detected
green represents Cu ions detected in CCM alone, red represents CuCl2 cont
scale bars are shown at bottom right of each image; c size distribution hist
determined by DLS; d size distribution histogram of CuO NP hydrodynamic d
histogram of CuO NP diameter, determined by TEMare metal oxide NPs which possess the capacity to
release ions, the concentration of Cu2+ ions in solution
was also assessed (Fig. 1a). The dissolution was studied
under the same conditions as those of the cellular exper-
iments, therefore within our CCM and during a time
course of 0, 1, 3, 6, 12, 24 and 48 h. We observed a time
dependent dissolution. A rapid dissolution was observed
between 3 and 6 h. To correlate with the metabolome
experiments, a CuO NP concentration of 10 μg/ml was
used, therefore a concentration of Cu2+ ions equivalent
to 8 μg/ml was expected if the NPs dissolved completely;
which was observed within 24 h of incubation. CCM
served as negative control, and was found to be <
0.05 μg/ml, and as positive control a copper (II) chloride
(CuCl2 · 2H2O) solution was used, this was suspended at
21.45 μg/ml to give a final copper concentration of 8 μg/
ml. Although optimal CuO dissolution has been shown
under highly acidic or highly basic conditions [43], we
have shown, as have others [28], that CuO NPs release
significant levels of Cu2+ ions in buffered CCM.
Determination of appropriate dose for untargeted
metabolomics study, using cytotoxicity and IL-8 secretion
induced in A549 cells
The concentration selection as well as the exposure
period for the untargeted metabolomics profiling ofuO NPs (maximum potential Cu ion release = 8 μg/ml, and would be
after incubation of CuO NPs in CCM for increasing lengths of time,
rol; b transmission electron microscopy (TEM) micrographs of CuO NPs,
ogram of CuO NP hydrodynamic diameter when suspended in water,
iameter when suspended in CCM, determined by DLS; e size distribution
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toxicity, and IL-8 secretion in response to a CuO NP
concentration range of 0–40 μg/ml for 4, 24 and 48 h,
the results are shown in Fig. 2. Almost complete cell
death was induced with exposures of ≥ 20 μg/ml for 24 h
and above, with a strong and statistically significant IL-8
secretion observed from exposures of ≥ 10 μg/ml during
the 24 and 48 h exposure periods. A final concentration
of 10 μg/ml, with 24 h exposure, was selected for subse-
quent metabolomics assays. Assessment of A549 cells in
response to CuO NPs in comparison to CuCl2 at corre-
sponding copper concentrations of 63–500 μM, was per-
formed for the same biological endpoints described
above. A similar pattern of dose- and time-dependent
cytotoxicity and IL-8 secretion was observed for each
material. However, these responses were shown to be
greater in response to CuO NPs than to corresponding
exposures of CuCl2 (Additional file 1: Figure S2).
Differential metabolome analysis of A549 cells in
response to CuO NPs
In order to profile the time-dependent responses of
metabolites upon exposure of A549 cells with 10 μg/ml
CuO NPs, six time points (0, 1, 3, 6, 12 and 24 h) were
tested and the cells’ metabolome was assessed in CuO
NP treated cells and cells incubated for the same time
period in CCM only. Principle component analysis
(PCA) is a statistical tool that can be used to visually ex-
plore the grouping pattern of all samples of the study,
where R2 and Q2 are used for evaluating the perform-
ance of the PCA model. The PCA score plots for the
CuO NP study demonstrated that in all four methods
used, chromatographic separation with reversed-phase
high-performance liquid chromatography (RP-HPLC)/
hydrophilic interaction liquid chromatography (HILIC)
and negative (neg)/positive (pos) electrospray ionization
followed by mass spectrometric detection, CuO NP ex-
posure induced a separation in the grouping ofFig. 2 Cell viability, cytotoxicity and IL-8 secretion in response to CuO NPs.
A549 cells treated with CuO NPs at 0, 2.5, 5.0, 10, 20 and 40 μg/ml for 4, 24 an
Each data point represents the mean ± SEM (n = 3). Statistical significance was
exposures, ^ for 24 h, and * for 48 h, when p < 0.05 compared to medium on
cytotoxicity assays, and TNF-α for IL-8 secretion (appear in red on each graph)regulated metabolites from the untreated cells after 6,
12 and 24 h (Fig. 3). Taking into consideration the
comprehensiveness of the features detected by all
methods together (Additional file 1: Figure S1), the
holistic view of metabolic processes influenced by
CuO NP treatment is well supported.
A similar result was observed when using the univari-
ate statistical approach. The pairwise comparison of con-
trol versus treated for each time point confirmed that
significantly regulated features were observed only for
the later time points (Fig. 4). Moreover, it can be seen
that through the time course of the experiment the
numbers in differentially regulated features continually
increased, highlighting the pronounced changes induced
by CuO NPs at a metabolite level. In order to perform a
biological interpretation, it is necessary to turn the (dif-
ferentially expressed) features (m/z values) into identi-
fied metabolites. This identification process is one of the
major bottlenecks in metabolomics studies. The reliabil-
ity of the assigned identification depends on how much
analytical information of a feature is available. There-
fore different levels of identification (levels 1, 1a and
2) have been proposed by Sumner et al. [41]. Accord-
ingly, 34 differentially regulated metabolites were identi-
fied in total according to level 1, 1a and 2 [41], which
were subsequently used for biological interpretation
(Additional file 1: Table S6).
The majority of the significantly regulated features we
found were not unambiguously identified and were
therefore not included in Additional file 1: Table S6,
which contained 34 differentially expressed metabolites.
In our case, an unambiguous identification needed a ref-
erence substance or a database reference tandem mass
spectrum that was highly similar to our acquired tandem
mass spectrum. The total number of features that were
differentially expressed upon CuO NP treatment is
shown in Additional file 1: Table S7. Amongst these fea-
tures were several candidates that were too low inDose finding experiments for the untargeted metabolomics profiling.
d 48 h and assessed for (a) cell viability (b) LDH release, c IL-8 secretion.
determined by ANOVA with Tukey posthoc, and identified with + for 4 h
ly treated cells. Positive controls used were Triton X-100 for viability and
Fig. 3 Principal Component Analysis Score plots showing controls (C) and treated samples (T) for the different time points (0 h, 1 h, 3 h, 6 h,
12 h, 24 h) and the biological replicates independently (n = 3) as datasets 1, 2, and 3. a reversed-phase HPLC - & positive ionization (RP_pos):
R2cum (0.591),Q2cum (0.481); b reversed-phase HPLC & negative ionization (RP_neg): R2cum (0.575),Q2cum (0.459); c HILIC & positive ionization
(pos) (without T.1 h.1, T.24 h.1): R2cum (0.732),Q2cum (0.586); d HILIC & negative ionization (neg) (without T.24 h.1): R2cum (0.618),Q2cum (0.542)
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therefore no unambiguous identification was possible.
Furthermore, some features could not be identified, as
the information gained in an HPLC-MS approach was
insufficient for identification, for example for phospha-
tidylethanolamines (PE), phosphatidylserine (PS), and
phosphatidylcholines (PC). These substance classes do
seem to be affected upon CuO NP treatment, however,
they were detected mainly using HILIC-negative ionization,
which, in general, was a separation method resulting in a
relatively high number of differentially expressed features.
The number of differentially expressed features
(Additional file 1: Table S7) is quite high when com-
pared to the number of unambiguously identified me-
tabolites (Additional file 1: Table S6), however, the
reliability of those reported in Additional file 1: Table
S6 appears to be high, as indicated within the table.
The differentially regulated metabolites shown in
Additional file 1: Table S6 belong to different classes and
play roles in various pathways. One possible approach forbiological interpretation is the use of pathway mapping
software. In this case Ingenuity Pathway Analysis (IPA)
[44] was used. The most affected cellular functions
were amino acid metabolism followed by molecular
transport, small molecule biochemistry, cellular growth
& proliferation, and organismal development. However,
these interpretations can only be generalised to the
overall output of the cells. For the purposes of this
study it was important to determine specific pathways
which relate to the toxicity of CuO NPs, and therefore
a focus was given to oxidative stress and apoptosis.
Metabolites identified, such as glutathione, cysteine-
glutathione disulfide, and citrulline were considered to
be associated with oxidative stress; while others, includ-
ing glycerophosphocholine (GPC), numerous amino
acids, myo-inositol, and 5’-methylthioadenosine (MTA)
were considered to be associated with apoptosis. These
points led to our “hypothesis” that CuO NPs induce
both oxidative stress and apoptosis. These points are
addressed within the discussion, and warranted further
Fig. 4 Number of significantly regulated features (p < 0.05) calculated using limma followed by Benjamini-Hochberg correction for multiple testing.
(a) reversed-phase HPLC & positive ionization (RP_pos) (b) reversed-phase HPLC & negative ionization (RP_neg) (c) HILIC & positive ionization
(HILIC_pos) (d) HILIC & negative ionization (HILIC_neg)
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dative stress and apoptosis.
Validation of metabolomics data using assessment of
oxidative stress
To determine if the trend of differently regulated me-
tabolites related to oxidative stress, which appeared
only after 6 h incubation, A549 cells were exposed to
0–40 μg/ml CuO NPs for 1, 3, 6, 12 and 24 h. The
intracellular GSH/GSSG ratios were assessed using a
luminescence-based method to detect total glutathi-
one and oxidised GSSG. This method permitted the
fast isolation of GSSG and therefore allowed to deter-
mine accurate GSH/GSSG ratios. A dose- and time-
dependent decrease in GSH/GSSG ratio was observed
(Fig. 5). Significant oxidation of glutathione occurred
in as early as 3 h with concentrations of 20 and
40 μg/ml, while all concentrations tested induced sig-
nificant glutathione oxidation during the latter two
time points. When considering the concentration used
in the metabolomics study, 10 μg/ml, it was evident
that a significant oxidation of glutathione only oc-
curred after 6 h, and remained for the duration ofthe experiment. Assessment of the cells’ response to a
redox imbalance at this time point was further corrobo-
rated with hemeoxygenase-1 (HO-1) mRNA expression
(Additional file 1: Figure S3), which, although significantly
upregulated after 3 h in response to the highest two con-
centrations tested, was only found in response to 10 μg/
ml after 6 h. Glutathione peroxidase 1 (GPX1) mRNA ex-
pression was also assessed under the same conditions
(Additional file 1: Figure S4). It was evident that only the
highest exposure concentrations, and predominantly the
longest exposure time of 24 h were sufficient for inducing
gene expression of this antioxidant.
Validation of metabolomics data using assessment of
apoptosis
Caspase-3 and −7 activity was assessed in response to
CuO NPs at 0–20 μg/ml (Fig. 6a), and to two further
substances, namely staurosporine (STS) (Fig. 6b) and
camptothecin (CPT) (Fig. 6c). The addition of the sec-
ond two substances (STS and CPT) would allow us to
gain confidence in metabolic markers which we may
propose as generic markers for apoptosis. Cells were ex-
posed to 0.5, 1, and 2 μM STS, or 8, 16, and 32 μg/ml
Fig. 5 Glutathione redox state in response to CuO NPs. A549 cells treated with CuO NPs at 0, 2.5, 5.0, 10, 20 and 40 μg/ml for 1, 3, 6, 12 and 24 h.
Data is expressed as GSH/GSSG ratio, and each data point represents the mean ± SEM (n = 4). Statistical significance (determined by ANOVA with
Tukey posthoc) is shown by * = p < 0.05, ** = p < 0.01, *** = p < 0.005, when compared to medium only treated cells
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increase in caspase activity was observed with exposure
of CuO NPs, with significant increases found in response
to 10 μg/ml (12 and 24 h) and 20 μg/ml (6, 12 and 24 h)
CuO NPs. STS induced a clear dose- and time-
dependent increase in caspase activity when compared
to untreated cells, with significantly increased activity in
response to 1 μM (12 and 24 h) and 2 μM (6, 12, and
24 h). The response to CPT was similar, althoughFig. 6 Apoptosis (caspase-3 and −7 activity) in response to CuO NPs, staur
NPs at 0, 2.5, 5.0, 10 and 20 μg/ml, (b) STS at 0.5, 1, and 2 μM, or (c) CPT at
and −7 activity. Data is expressed as % enzyme activity compared to mediu
(n = 3). Statistical significance was determined by ANOVA with Tukey posth
to medium only treated cellsincreased activity was observed at all concentrations
tested, 8 μg/ml (24 h), 16 μg/ml (24 h), 32 μg/ml (6, 12,
and 24 h). However, although both substances induced
apoptosis, indicated by a strong caspase activity, STS
was shown to induce an early activation of caspases at
low concentrations (in respect to the dose range used
here), while CPT needed higher concentrations (in re-
spect to the dose range used here) and a clear dose re-
sponse was only observed during the latter time points.osporine (STS) and camptothecin (CPT). A549 cells treated with (a) CuO
8, 16, and 32 μg/ml; for 3, 6, 12 and 24 h and assessed for caspase-3
m only treated cells, and each data point represents the mean ± SEM
oc, and + for 6 h, ^ for 12 h and * for 24 h, when p < 0.05 compared
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account for the study design of the subsequent metabo-
lomics experiment.
Differential metabolome analysis of STS and CPT, and
comparisons to CuO NPs
Untargeted metabolomics was used to compare the dif-
ferentially expressed metabolites of untreated cells to
those expressed with treatments of STS and CPT, with
exposure times of 0, 3, 6, 12, 24 h for STS and 0, 6, 9,
12, 24 h for CPT, and concentrations of 1 μM STS
(0.5 μg/ml) and 16 μg/ml CPT.
The metabolomics data generation and processing
were carried out in accordance to the CuO NP toxicity
study, again including data normalized to cell number
(Additional file 1: Table S3). The statistical evaluation of
the metabolomics data detected similar trends to those
observed in the caspase activity assays. Limma as well as
PCA identified that differences between control and
treated samples occurred from 6 h onwards for STS,
while for CPT differences were observed from 12 h
onwards. Although the treatment with STS induced
metabolic changes more rapidly, after 24 h of exposure
more metabolic features were differentially expressed
upon incubation with CPT than STS, this is visualized
by the grouping in the principal component analysis
plots (Fig. 7). Notably, this approach signalled that,
although both STS and CPT induced apoptosis in A549
cells, different metabolites were involved.
All three apoptotic agents, CuO NPs, STS, and
CPT, induced a differential expression of metabolites,Fig. 7 Principal Component Analysis score plot showing controls (C), staur
(CPT) for the different time points (0 h, 3 h, 6 h, 9 h 12 h, 24 h) and biolog
K3) for the HILIC negative dataset (R2(cum) 0.731 and Q2 (cum) 0.684)presented as a heat map in Fig. 8. However, although
frequently similar, the dendrograms indicated that the
induction patterns generated by each agent were also
often markedly different. The colour coding in Fig. 8
indicates the extent of upregulation (red) or downreg-
ulation (blue) of a certain metabolite and further elu-
cidates trends, such as successive downregulation of
sphingosine over time upon treatment with STS. An
accumulation of the various amino acids was observed for
all three treatments. However, although a strong time-
dependent upregulation was observed in response to CuO
NPs, MTA was unaltered in response to STS or CPT. Fur-
thermore, GPC regulation in response to STS was shown
to have no association with exposure time, while for both
CuO NPs and CPTa strong time-dependency was evident.
Other metabolites differentially regulated in all three treat-
ments included glutathione, sphingosine, phosphocrea-
tine, and methylnicotinamide (MNA).
In most cases, however, uniformity of response was
not observed, as glutathione was increased in re-
sponse to CPT and decreased in response to CuO
NPs and STS. A strong time-dependent decrease in
sphingosine was observed in response to STS, while
CPT induced a strong time-dependent increase and
CuO NPs, although decreasing sphingosine, did so in-
dependent of exposure time. Additionally, phospho-
creatine was shown to increase in response to CPT,
and decrease in response to STS and CuO NPs. How-
ever, MNA was found to be strongly and time-
dependently up-regulated within all three treatments
(Additional file 1: Figure S5).osporine treated samples (STS) and camptothecin treated samples
ical replicates shown independently (n = 3, identified with K1,K2, and
Fig. 8 Heatmap showing log2 fold changes for treatments of staurosporine (STS), camptothecin (CPT) and copper oxide nanoparticles (CuO NPs)
for the various time points (n = 3), the levels of identification are indicated by 1identified by reference substance (MS2 and RT), 1aidentified by
reference substance (only RT), 2identified by comparison of MS2 spectra with reference databases such as Metlin. The dendrogram on the left
hand side shows a clustering of similarly regulated metabolites upon treatment with STS/CPT/CuO NPs
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Toxicity of CuO NPs in A549 cells
In experiments used to determine the appropriate dose
for untargeted metabolomics study, including cytotox-
icity and IL-8 secretion, CuO NPs were found to induce
almost complete cell death in A549 cells when exposed
with concentrations of 20 μg/ml or greater, by the 24 h
exposure interval. At the lower concentration of 10 μg/
ml a statistically significant pro-inflammatory response
was observed during the 24 and 48 h exposure periods.
This is in line with current literature regarding copper
NP toxicity [17, 26, 27, 45–47], and confirmed that the
CuO NPs used in this study are highly capable of indu-
cing strong pro-inflammatory conditions and inducing
substantial cell death. As we had shown relatively rapid
dissolution of CuO NPs in CCM, although not a main
focus of this study, we also addressed whether the bio-
logical responses described above can be attributed
solely to Cu2+ toxicity, or whether copper presented in
the form of NPs can exacerbate biological responses.
This was tested by comparing the CuO NPs and CuCl2
at the same copper concentrations, and assessing the re-
sponse of A549 cells in terms of cell death, viability and
secretion of the pro-inflammatory cytokine IL-8. CuO
NPs at the same copper concentrations as CuCl2 would
consistently and significantly reduce A549 cell viability,
increase cytotoxicity and increase pro-inflammatorymediator release to a greater extent than CuCl2. This
effect has often been reported [24, 28, 48, 49] and is pos-
tulated as the Trojan horse mechanism [31], in which
large quantities of copper are delivered into the cell in
the form of particles, with subsequent rapid dissolution
within acidic lysosomes [50], which, when present at
high concentrations, Cu2+ ions may induce formation of
reactive oxygen species, induce DNA strand breaks, and
lipid peroxidation [51]. However, to distinguish discern-
ible differences within the cells’ metabolome dependent
upon whether the insult is via copper particles or Cu2+
ions is outside the scope of this study.
The dose- and time-dependent effects of CuO NPs
on A549 cell death and inflammation were used to se-
lect concentrations and exposure times appropriate for
the untargeted metabolomics profiling assays. As we
desired to investigate sublethal concentrations, which
would still elicit a measureable adverse response, we se-
lected a final concentration of 10 μg/ml to be used in
our metabolomics approach, with maximum exposure
times of 24 h.
Biological interpretation and validation of metabolomics
– focus on oxidative stress markers
The metabolomics approach revealed a depletion of the
reduced form of glutathione (GSH) and an increase in
the oxidized form of glutathione (glutathione disulfide,
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accompanied with an increase in cysteine-glutathione di-
sulfide, was indicative of antioxidant activity [52–54]
and therefore oxidative stress. This was further corrobo-
rated by the elevated levels of citrulline, a product of
nitric oxide formation [55–57]. Therefore, the first hy-
pothesis to be generated upon the metabolomics ap-
proach was that CuO NPs induce oxidative stress. This
is a process repeatedly reported concerning biological
responses to CuO NPs [29, 30, 32, 45], and was validated
within our study using a more conventional detection of
glutathione oxidation and reduction states, and mRNA
expression of antioxidants. A clear dose- and time-
dependent increase in GSSG was found, indicating a sig-
nificant oxidation of glutathione. In terms of the concen-
tration used for the metabolomics study, 10 μg/ml, it
was evident that a significant oxidation of glutathione
only occurred after 6 h. This aligns relatively well with
the data generated from assessing the cells’ whole me-
tabolome; although the metabolomics data may provide
a more sensitive assessment as, although significant dif-
ferences in GSH were also observed here at 6 h, GSSG
was found to significantly increase from 3 h onwards.
When assessing antioxidant gene expression, it was ob-
served that transcription of both HO-1 and GPX1 genes
occurred in response to CuO NPs. However, HO-1 gene
expression occurred at lower particle concentrations and
at earlier time points. Although activity of HO-1 is well re-
ported in response to Cu NPs [46, 58, 59], GPX1 is less so,
and in fact has been shown to decrease in response to Cu
NPs [60]. Although dual assessment of HO-1 and GPX1
has not been performed elsewhere in CuO NP studies, the
decreased sensitivity of GPX1 detection (or induction) can
be corroborated in in vitro studies. Using CNTs exposures
of mouse macrophages, an increase in HO-1 gene expres-
sion was found within 6 h in response to CNTs in the
absence of GPX1 [61], a finding also observed by Chou
et al. [62] in the treatment of human monocyte-derived
macrophages with SWCNTs. This was further corrobo-
rated by Bussy et al. [63] who observed a rapid expression
of HO-1, in the absence of GPX1, with exposure of mouse
macrophages with CNTs, while prolonged exposures in-
duced significant expression of both these markers [63].
Our data implies that HO-1 and glutathione oxidation
are certainly more sensitive and earlier markers for
CuO NP induced oxidative stress, compared to GPX1,
with time kinetics of each coinciding, indicating that
glutathione would be a suitable marker to use for me-
tabolome screening.
Biological interpretation and validation of metabolomics
– focus on apoptosis markers
An additional goal in conducting this study, to determine
potential markers of apoptosis, was more challenging toaccomplish. We identified certain metabolites in response
to CuO NPs which could be interpreted as being involved
in cell death, including elevated levels of GPC, various
amino acids, myo-inositol, and MTA; all of which have
been associated with hypertonic stress and/or apoptosis
[64–72]. The potential of CuO NPs to induce hypertonic
stress is in itself an interesting point to consider. The rela-
tively specific signaling cascades, which can occur in
response to changes in osmolarity, may provide novel un-
derstanding of toxicity mechanisms induced by CuO NPs
and NPs in general. For example, the activation and phos-
phorylation of the Rel family protein NFAT5 is induced by
hypertonicity [66], as is NF-kB phosphorylation [73]. Acti-
vation of NFAT5 promotes pro-inflammatory responses
such as TNF-α secretion in T cells [66], IL-1β and TNF-α
secretion in epithelial cells [74]. This activity differs from
other Rel proteins (NFATc), as activation of NFAT5 is
thought to be independent from intracellular calcium-
regulated effects [66]. As intracellular calcium regulation
is a commonly reported mode of action in nanotoxicology
[75–78], the possibility that CuO NPs employ mecha-
nisms distinct from this, i.e. osmotic stress and NFAT5 ac-
tivation, is an interesting observation. It is clear that these
issues would need further study to distinguish if one or
both mechanisms are relevant for the results found
here. Furthermore, the regulation of NFAT5 derives not
only from osmotic stress, but also from growth factors,
cytokines, ROS, and ions, for example [79]. The associ-
ation of CuO NPs and other metal NPs (with responses
attributed to ion release) with osmotic effects has already
been made in the assessment of microorganisms such as
algae [80] and bacteria [81, 82], and in aquatic systems
[83]. In mammalian nucleated cells, associations between
metal NPs and osmotic stress-induced responses are
far less reported. Gold NPs have been shown to in-
duce transcription of genes associated with osmotic
stress in HEp-2 cells [84].
All amino acids detected were shown to accumulate
here upon treatment with CuO NPs over time, as was
myo-inositol. This accumulation of amino acids [64, 65],
and myo-inositol [66], have both previously been associ-
ated with hypertonic stress. Furthermore, as the events
associated with osmotic stress, such as apoptotic volume
decrease (AVD), have been reported to occur prior to
many standard markers of apoptosis, such as caspase ac-
tivity, cytochrome c release, or DNA laddering [85], it is
plausible that this increase in amino acids residing intra-
cellularly could be an early marker for the initiation of
apoptosis. This is also supported by reports that amino
acid accumulation (Gln especially) results in non-
physiological conditions that play a decisive role in regu-
lation of stress responses, such as encouraging heat
shock proteins expression [86, 87]. We also observed an
intracellular accumulation over time of GPC in response
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served level (14-fold increase compared to untreated
cells) after 24 h. GPC is a degradation product of phos-
phatidylcholine, and has also been long associated with
protective functions during osmotic stress [67], has been
reported in association with apoptosis [68–70], and as a
biomarker for effects of NPs on biological systems [88].
MTA was also considered as a potential metabolome
candidate marker for apoptosis. We found levels of
MTA to significantly increase from 3 h onwards, and
amongst several important cellular functions, including
roles in gene expression and proliferation, MTA is con-
sidered to be involved in the regulation of, and even to
promote, apoptosis [71, 72]. The rise in the aforemen-
tioned metabolites provides an indication of their in-
volvement in apoptotic events induced by CuO NPs,
and, moreover, the GPC found elevated here in re-
sponse to CuO NPs has also been observed in response
to other NPs elsewhere, such as gold nanorods [89].
Moreover, MTA levels were shown to decrease in kera-
tinocytes in response to TiO2, while aptoptosis was not
detected [90].
To validate whether these events may relate to apop-
tosis, and to confirm whether the CuO NPs tested here
induce apoptosis, a more conventional apoptosis assay
was performed as comparison, by measuring the activity
of caspase-3 and −7. These are cysteine proteases known
to play mediatory roles in both mitochondrial-mediated
and death receptor-mediated apoptosis [91]. This assay
was performed in conjunction with further untargeted
metabolomics and determination caspase-3 and −7 ac-
tivity in A549 cells in response to STS and CPT, to fur-
ther clarify the involvement of our identified metabolites
in apoptosis, and to gain some assurance of their
strength as generic markers for apoptosis. Both STS and
CPT are known to induce apoptosis [92, 93], and were
shown to do so here.
The increase of specific metabolites we perceived to be
indicative of CuO NP-induced apoptosis was often dis-
similar when comparisons were made to STS and CPT
induced responses. MTA was unaffected by STS and
CPT. While GPC was elevated in response to CPT over
time, the response to STS did not follow any time-
dependent responses. With other metabolites also not
following a strict conformity between treatments, such
as glutathione, sphingosine, and phosphocreatine, these
findings infer that the differential metabolite pattern of
CuO NP treated cells was often dissimilar to STS and
CPT. Furthermore, excluding amino acid levels (which
were consistent across treatment methods), the previ-
ously determined metabolites GPC and MTA, although
potential markers for CuO NP induced apoptosis, were
considered to be inappropriate generic markers for
apoptotic events. However, the strong time-dependentupregulation of MNA in response to all three treatments
highlights this metabolite a potential generic screening
option for apoptosis.
MNA is formed of nicotinamide and s-
adenosylmethionine (SAMe), through the transfer of
the methyl group of SAMe to nicotinamide by nico-
tinamide N-methyltransferase (NNMT) [94]. MNA
detection has been used for disease diagnostic purposes,
such as in determination of atherosclerosis [95]. Further-
more, although previously thought of as an inactive me-
tabolite, MNA is now considered to be an active
metabolite of nicotinamide, and its anti-inflammatory ac-
tivities have led to its use in the treatment of inflammatory
conditions such as thrombolysis [96] and rosacea [97]. In
terms of NPs, MNA levels have been altered, in vivo, in
response to iron oxide and manganese NPs [98–100]. Al-
though MNA upregulation has not previously been
reported in response to CuO NPs, there is significant
inference of its effect in the present study, as MNA has
previously been shown to induce DNA fragmentation in
HL-60 cells [101]. All three treatments used here, CuO
NPs, STS, and CPT, have been shown to induce significant
increases in this metabolite, and all have also been shown
to induce DNA strand breaks elsewhere [24, 28, 92, 93], it
is, therefore, possible that MNA could be presented as a
marker for DNA damage which leads to apoptosis. To
confirm this proposed mode of action, absolute quantifica-
tion of MNA in the cell lysates would be necessary and
the determined concentration used for treatment of A549
cells, with subsequent measurements of DNA strand
break; this, however, is beyond the scope of this study and
a matter of ongoing research.
Scope of untargeted metabolomics in nanosafety testing
For untargeted metabolomics methods to be of use in
nanotoxicological testing, a number of points need to be
considered: i) can untargeted metabolomics be consid-
ered a more sensitive method for determining NM-
induced biological responses, in comparison to more
conventional methods? ii) Is there extra information
to be gained from performing untargeted metabolomics in
comparison to conventional methods, and how can it
be used?
I) It is important to assess the sensitivity of techniques
such as those used here when establishing the usefulness
and appropriateness of employing untargeted metabolo-
mics in nanosafety assessment. When comparing the
statistically significant regulation of A549 cells’ metabo-
lome in response to CuO NPs to the responses observed,
at the same particle concentration, using the more con-
ventional methods a number of observations can be
made. In terms of markers for oxidative stress, a signifi-
cant alteration of GSH/GSSG ratios was observed at 6 h
using the conventional method, and mRNA expression
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Markers for oxidative stress within the metabolome were
at times decidedly different. The decline of GSH was
only observed to be significant after 12 h, the same ob-
servation was made for citrulline. However, cysteine
glutathione disulfide was elevated at 6 h, and the in-
crease in oxidised glutathione (GSSG) was statistically
significant after just 3 h. This highlights that the breadth
of information gathered with metabolomics allows earl-
ier and therefore more sensitive detection of oxidative
stress induced by CuO NPs.
The same distinction in sensitivity can be made in
terms of apoptosis; using conventional assessment of
caspase-3 and −7 activity we observed a significant in-
crease after 12 h exposure of 10 μg/ml. At this same
concentration, markers perceived to be associated with
apoptosis were altered time-dependently: GPC increased
after 12 h, myo-inositol after 6 h, while MNA, MTA and
Gln were all significantly increased after just 3 h. Again
highlighting that the breadth of features detected
allowed for a more sensitive assessment.
II) There is currently a growing opinion that the way
in which toxicology is assessed for regulatory purposes is
not fully sufficient [102]. This is based on limitations of
animal models as comparisons to humans, but also of
the need of in vivo studies to often use maximum toler-
ated doses, to remain time- and cost-effective [102]. Fur-
thermore, with the exponential growth of nanotechnology
and materials pertaining to it, new schemes and alterna-
tive testing strategies which operate within the 3Rs
principle are essential, and in current times ethically pru-
dent [103, 104]. For example, REACH are encouraging an
integrated approach to toxicological testing, where in vivo,
in vitro and in silico methods are used [102]. To be of use,
it is proposed that the relevant data be incorporated into
conceptual schemes, such as adverse outcome pathways
(AOPs), which allow the linking of early molecular events
to the eventual adverse outcome in an organism [105].
Part of these initiatives involve the determination of
modes of action, which is where use of omics techniques,
such as metabolomics, is considered paramount [102].
Metabolomics has developed rapidly as a new discipline to
be used within these schemes and offers an opportunity
for a screening approach, to discover new metabolites that
are effected upon NP treatments.
The focus of this present study was to establish whether
untargeted metabolomics could identify markers of key
toxicity pathways associated with CuO NPs. Here, in this
proof of principle study, we have demonstrated that meta-
bolomics can detect specific markers of both oxidative
stress and apoptosis, and that this method also allows the
distinction between molecules involved in the apoptotic
pathways of mechanistically different stimuli (CuO NPs,
STS, and CPT), but also those molecules found to havehomogeneity across different stimuli. At this stage we are
confident in the techniques which have been used, and in
our propositions for pathway markers. It is beyond the
scope of one study to evaluate all of the pathways implied
by this analysis of the cells’ whole metabolome. Including
the potentially novel CuO NP toxicity mechanisms associ-
ated with changes in osmolarity, the assessment of agents
contributing or causing DNA damage, determination of
whether a response to copper particulates differs from
copper ions, or whether copper particles of different
shapes or sizes can affect the cells’ metabolome in
different fashions. These questions remain important
for ongoing research, as there are very few published
metabolomics studies focusing on NPs.
To the best of our knowledge, no other study has de-
termined the metabolic profile in response to CuO NPs,
or NPs in general, in lung epithelial cells in vitro. Of the
current published research there are few studies which
have determined the metabolic profile induced by other
NPs and/or in other systems, such as the copper NP
exposure of rats by oral gavage [9]. Furthermore, with
intravenous exposures of nano- and submicron-sized
silica particles a metabolic analysis of liver toxicity
demonstrated that both particle sizes induced a similar
metabolite profile [106]. However, the main focus of
metabolomics in nanosafety testing has been on TiO2.
Including the assessment of earthworms [11], intratra-
cheal or intragastric exposure of TiO2 to rats [107, 108],
and various mammalian cell in vitro responses to TiO2
[109–111], but also the in vitro exposure of Caco-2 cells
with gold NPs of different sizes, in which the different
sized Au NPs were shown to induce similar metabolic
profiles [112]. It is unclear whether Cu2+ would exert
the same effect as we have observed for CuO NPs, or
even whether other metal oxide NPs would do so. For
example, in a study by Garcia et al. [110], TiO2 induced
a different metabolite profile in fibroblasts than the one
observed here. Those metabolites which were increased
and implicated in toxic responses here (MNA, GPC, and
amino acids) were found to decrease in response to
treatments of TiO2 alone [110], which were of a similar
size to the CuO NPs used here. While levels of glutathi-
one where unchanged in response to TiO2 [110], CuO
NPs decreased GSH here. Conversely, in HepG2 cells
TiO2, again of a similar size, were shown to reduce
glutathione levels [109]. However, again, our metabolites
of note (MTA and GPC) were unchanged in TiO2 expo-
sures (only exposures of TiO2 of a relatively larger size
(~100 nm) induced GPC elevation); MNA was not
reported [109].
Conclusion
We assessed the toxicity mechanism of CuO NPs in
A549 cells and have found that it involves strong pro-
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grammed cell death, accompanied by a significant alter-
ation of the cells’ metabolic activity. Toxicity of CuO
NPs has been shown to be greater than that of corre-
sponding concentrations of Cu2+ ions. To the best of
our knowledge, no other study has performed a CuO
nanotoxicological/metabolomics study to this technical
level; specifically, we focused on thorough quality con-
trol and stringent validation of the metabolome data by
carrying out dedicated conventional cellular and bio-
chemical assays in order to provide a subsequent critical
testing of the hypotheses generated by HPLC-MS, which
adds great strength to the suppositions of this research.
The untargeted metabolomics approach was shown to
be a particularly sensitive method, and able to detect
subtle metabolic changes in A549 cells upon exposure of
CuO NPs. Although not absolute, relative quantification
was possible, and it has been shown here to provide, in
one experiment, an answer that would normally need
multiple dedicated cell assays for specific endpoints;
highlighting untargeted metabolomics as a suitable tool
for the high-throughput screening of NPs.
Ultimately, only the normalization of metabolic ex-
pression patterns to decreasing cell numbers upon treat-
ment with toxic substances allows an unbiased view.
Thus it is mandatory to apply suitable normalization
parameters. For untargeted metabolomics to be used as
a suitable high-throughput screening tool, however, it is
important to obtain strong, reproducible markers, in this
case for pathways which are well reported in CuO NP
induced toxicity, oxidative stress and apoptosis. As ex-
pected, the well-recognized marker for oxidative stress,
ratios of reduced and oxidized glutathione, was estab-
lished in both metabolic and conventional detection
assays, while assured markers for apoptosis were more
difficult to identify. Ultimately, MNA is tentatively sug-
gested as a strong metabolic marker for apoptosis, as it
not only was found in response to CuO NPs but also
other compounds which use mechanistically distinct
pathways of apoptosis induction. This hypothesis will
need further testing and validation with a broader
range of NPs. However, we have demonstrated here
that the use of metabolomics in this fashion can pro-
vide molecular mapping of toxicity pathways, which
can contribute to the development of AOPs, but also
can be used as a tool for hypotheses generation and
toxicity screening.Additional file
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